Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumiya Ogasawara

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Internal Medicine (Tokyo, Japan)|June 22, 2022
Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman DiseaseKazuto Togitani, Fumiya Ogasawara, Yu Arakawa, et al.
Journal of Cellular and Molecular Medicine|October 9, 2022
Targeting VEGF with bevacizumab inhibits malignant effusion formation of primary human herpesvirus 8-unrelated effusion large B-cell lymphoma in vivoFumiya Ogasawara, Tomonori Higuchi, Tomohiro Nishimori, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|October 28, 2021
Glucocorticoid-induced redistribution lymphocytosis in mantle cell lymphoma with hyaline vascular Castleman disease-like featuresKazuto Togitani, Mitsuko Iguchi, Tadashi Asagiri, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 4, 2018
Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlapYusuke Takayama, Hiroshi Ohnishi, Fumiya Ogasawara, et al.
International Journal of Hematology|March 31, 2026
Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 studyFumiya Ogasawara, Yosuke Minami, SungGi Chi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 8, 2021
[Acquired hypofibrinogenemia in patients with leukemia during steroid therapy]Fumiya Ogasawara, Takehiko Ito, Makoto Nakamura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 14, 2023
Unilateral lymphadenitis caused by community-associated methicillin-resistant Staphylococcus aureus ST834 strainHitomi Eda, Yu Arakawa, Takuma Yoshida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 8, 2025
[Primary hepatic diffuse large B-cell lymphoma developed in a patient with primary biliary cholangitis]Shinichiro Watanabe, Kosuke Nakaji, Tsunehiro Ochi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2023
[Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease]Keito Ohara, Noriko Tsuge, Shinichiro Watanabe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 8, 2022
[Diagnostic efficacy of WT1 expression in asymptomatic acute promyelocytic leukemia]Hitomi Eda, Shinichiro Watanabe, Fumiya Ogasawara, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Internal Medicine (Tokyo, Japan)|June 22, 2022
Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman DiseaseKazuto Togitani, Fumiya Ogasawara, Yu Arakawa, et al.
Journal of Cellular and Molecular Medicine|October 9, 2022
Targeting VEGF with bevacizumab inhibits malignant effusion formation of primary human herpesvirus 8-unrelated effusion large B-cell lymphoma in vivoFumiya Ogasawara, Tomonori Higuchi, Tomohiro Nishimori, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|October 28, 2021
Glucocorticoid-induced redistribution lymphocytosis in mantle cell lymphoma with hyaline vascular Castleman disease-like featuresKazuto Togitani, Mitsuko Iguchi, Tadashi Asagiri, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 4, 2018
Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlapYusuke Takayama, Hiroshi Ohnishi, Fumiya Ogasawara, et al.
International Journal of Hematology|March 31, 2026
Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 studyFumiya Ogasawara, Yosuke Minami, SungGi Chi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 8, 2021
[Acquired hypofibrinogenemia in patients with leukemia during steroid therapy]Fumiya Ogasawara, Takehiko Ito, Makoto Nakamura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 14, 2023
Unilateral lymphadenitis caused by community-associated methicillin-resistant Staphylococcus aureus ST834 strainHitomi Eda, Yu Arakawa, Takuma Yoshida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 8, 2025
[Primary hepatic diffuse large B-cell lymphoma developed in a patient with primary biliary cholangitis]Shinichiro Watanabe, Kosuke Nakaji, Tsunehiro Ochi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 10, 2023
[Management of iron overload during pregnancy and childbirth in a patient with ferroportin disease]Keito Ohara, Noriko Tsuge, Shinichiro Watanabe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 8, 2022
[Diagnostic efficacy of WT1 expression in asymptomatic acute promyelocytic leukemia]Hitomi Eda, Shinichiro Watanabe, Fumiya Ogasawara, et al.
Pageof 2